This collaboration with ORA represents a major milestone in DIAGNOS' expansion strategy. With extensive experience in guiding ...
FDA feedback confirms Adial's proposed in vitro bridging strategy to the Phase 3 formulation to fulfill the bridging ...
Eli Lilly releases cheaper vials of the weight-loss drug for self-paying patients and cuts the price of two existing doses.
DOGE reportedly fired members of the FDA’s cardiac devices unit, which oversees devices like pacemakers and implantable defibrillators.
USDA is working to get more eggs into the supply chain in the short-term, but U.S. Agriculture Secretary Brooke Rollins says ...
The death toll rose to 12 people in the Listeria outbreak tied to frozen supplemental shakes sold to long-term care facilities, according to CDC. Pope Francis remains in critical condition but showed ...
“Companion animals, and especially cats, are 100% a public health risk in terms of the risk of zoonotic transmission to ...
Hosted on MSN50m
Scarborough slams DOGE layoffs for making red states 'suffer'Many right-wing media pundits are applauding President Donald Trump and the Elon Musk-led Department of Government Efficiency ...
Pharmalittle: We’re reading about Zepbound price and dose changes, compounders suing FDA, and more
Eli Lilly will offer more doses of its obesity drug Zepbound in vials and lower the prices of the doses it already sells ...
Megafine currently operates two USFDA-approved manufacturing facilities located in Nashik, Maharashtra, and Vapi, Gujarat, ...
Discover CheekAge, a groundbreaking epigenetic test using cheek swabs to predict biological aging and health risks, reshaping ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback